Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    Open Studies | "Lupus Erythematosus, Discoid"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Lupus Erythematosus, Discoid" (3 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus
Conditions: Lupus Erythematosus, Discoid;   Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Chronic Cutaneous
Intervention: Drug: Etanercept
2 Recruiting Autologous Polyclonal Tregs for Lupus
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic
Intervention: Biological: Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells
3 Recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Interventions: Drug: milatuzumab;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.